Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.33 |
| ▸ | POLRMT | O00411 | 1/20 | 0.32 |
| ▸ | GJB2 | P29033 | 1/20 | 0.32 |
| ▸ | PDE2A | O00408 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4971379 | 1.00 | DOT1L (0.33) | DOT1LPOLRMTGJB2PDE2A | |
| SCHEMBL15605849 | 0.91 | DOT1L (0.34) | DOT1LPOLRMTGJB2 | |
| SCHEMBL15259017 | 0.85 | GJB2 (0.32) | GJB2PDE2A | |
| SCHEMBL18787326 | 0.85 | GJB2 (0.32) | GJB2PDE2A | |
| SCHEMBL4970295 | 0.84 | GJB2 (0.31) | GJB2PDE2A | |
| SCHEMBL4970178 | 0.84 | GJB2 (0.31) | GJB2PDE2A | |
| SCHEMBL17131381 | 0.83 | DOT1L (0.39) | DOT1LPOLRMT | |
| SCHEMBL19227796 | 0.81 | PDE2A (0.49) | GJB2PDE2A | |
| SCHEMBL18636426 | 0.81 | PDE2A (0.49) | GJB2PDE2A | |
| SCHEMBL18571873 | 0.80 | GJB2 (0.30) | GJB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170226140-A1 | 2' FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. | 2017-08-10 | — | — | US | disclosed |
| US-20120107274-A1 | 2'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226140-A1 | 2' FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | PNP, NUDT1, NSUN2 | DOT1L 1221/4885POLRMT 103/4885GJB2 3616/4885 |
| US-20120107274-A1 | 2'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | PNP, NUDT1, SLC29A2 | DOT1L 1151/4885POLRMT 103/4885GJB2 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.